IndieBio

NanoPlume is a biomaterial manufacturer specializing in the large-scale production of innovative, eco-friendly biomaterials, notably Bio-Aerogel. The company focuses on creating advanced insulating biomaterials and aerogels, aiming to enhance energy and space efficiency, as well as promote circularity across various industries. By utilizing organic and recycled feedstocks and green technology, NanoPlume reduces waste and minimizes energy consumption. Its products are designed to insulate cargo boxes in the cold chain healthcare logistics sector, reducing payload and energy consumption, and extending battery range.

Minutia is a biotechnology company focused on developing innovative stem cell-derived transplants aimed at treating Type 1 Diabetes. The company specializes in creating insulin-producing cell transplants that incorporate proprietary nanosensors, allowing for real-time monitoring of transplant status. These immune-evasive cells are designed for subcutaneous implantation, addressing common challenges associated with transplant procedures. By advancing this technology, Minutia seeks to transform the clinical landscape for diabetes management and cell replacement therapies, ultimately working towards a functional cure for this condition.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Unibaio develops biodegradable nano-encapsulation technology that optimizes agrochemical delivery. Its particles enable pesticide companies to modify formulations, meeting stringent environmental regulations without replacing chemicals used by farmers. This reduces application doses and toxicity levels, lowering farmer costs and improving yields.

Gozen Bioworks offers solutions and biomaterials developed with a biomimicry approach by combining science, art, philosophy, and design to raise awareness and provide help to the planet, living creatures, and humanity. They develop and invent high-performance microbe-derived materials from natural inputs, such as next-generation leather, biotextiles, bioplastics, packaging, and interior materials.

Vader Nanotechnologies focuses on developing innovative organisms and enzymes aimed at addressing environmental challenges, particularly in recycling plastics and degrading persistent chemicals like PFAS. The company employs advanced techniques such as automation, image processing, computer vision, and analytical chemistry to identify and optimize strains capable of thriving on these difficult-to-break-down substances. By utilizing directed evolution methods, Vader enhances the performance of these organisms, contributing to solutions that tackle pressing environmental and health issues.

BioFeyn develops aquafeed ingredients that enhance the nutrition and sustainability of farmed fish. By optimizing marine ingredients and applying biodegradable nanoencapsulation, the company improves digestion, absorption, and bioavailability of nutrients, enabling delivery to specific tissues. This targeted delivery supports healthier growth and disease prevention in fish while reducing environmental pollution. The approach combines modular nutrient delivery with natural disease preventatives, helping clients produce farmed fish that are both nutritious and more sustainable.

Kraken Sense develops an automated pathogen detection platform that uses cutting-edge nanotechnology and IoT-enabled dashboard for real-time bacterial contamination monitoring.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

Founded in 2011, Dahlia Biosciences is a biotechnology company specializing in single-cell RNA analysis tools for research and diagnostic applications. It uses CRISPR-Cas9 technology to detect multiple DNA and RNA biomarkers directly in cells and tissues.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.

ViaeX Technologies Inc. specializes in the development and manufacturing of bio-engineered nano-membrane technology solutions aimed at purifying water and air. The company's innovative biological nanofiltration systems are designed to be 400% more efficient than conventional methods, targeting specific pollutants and bacteria. These systems are biodegradable, cost-effective, and easily scalable, making them suitable for rapid deployment in cities facing significant pollution challenges. ViaeX's focus is on creating energy-efficient and environmentally friendly filtration systems that cater to industrial and municipal needs. The company's technological advancements are grounded in extensive research conducted at UC Berkeley and UC San Diego, utilizing breakthroughs in physical chemistry and nanotechnology. Additionally, ViaeX is developing sustainable nanomaterials from bio-waste, which can be applied across various industries, including water purification and food filtration, thereby reducing dependency on traditional materials and contributing to a more sustainable future.

Vali Nanomedical Corporation is a biotechnology company established in 2013 and headquartered in Los Angeles, California. The company specializes in developing a multidrug-delivery platform that utilizes proprietary nanoparticles with unique multilayered structures. This innovative technology enables a single nanoparticle to transport multiple drugs to tumors simultaneously, facilitating advanced cancer combination therapies that were previously unattainable. Vali's approach aims to enhance the specificity, efficacy, and safety of cancer treatments, offering healthcare providers new opportunities in the fight against cancer.